Found: 35
Select item for more details and to access through your institution.
The impact of pre-processing and disease characteristics on reproducibility of T2-weighted MRI radiomics features.
- Published in:
- MAGMA: Magnetic Resonance Materials in Physics, Biology & Medicine, 2023, v. 36, n. 6, p. 945, doi. 10.1007/s10334-023-01112-z
- By:
- Publication type:
- Article
Pseudo-T2 mapping for normalization of T2-weighted prostate MRI.
- Published in:
- MAGMA: Magnetic Resonance Materials in Physics, Biology & Medicine, 2022, v. 35, n. 4, p. 573, doi. 10.1007/s10334-022-01003-9
- By:
- Publication type:
- Article
<sup>18</sup>F-Fluciclovine PET/MRI for preoperative lymph node staging in high-risk prostate cancer patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Spatial differentiation of metabolism in prostate cancer tissue by MALDI-TOF MSI.
- Published in:
- Cancer & Metabolism, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40170-021-00242-z
- By:
- Publication type:
- Article
Cholesterol synthesis pathway genes in prostate cancer are transcriptionally downregulated when tissue confounding is minimized.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Geometric distortion correction in prostate diffusion‐weighted MRI and its effect on quantitative apparent diffusion coefficient analysis.
- Published in:
- Magnetic Resonance in Medicine, 2018, v. 79, n. 5, p. 2524, doi. 10.1002/mrm.26899
- By:
- Publication type:
- Article
Spermine and Citrate as Metabolic Biomarkers for Assessing Prostate Cancer Aggressiveness.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0062375
- By:
- Publication type:
- Article
Disease-specific outcomes of Radical Prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time.
- Published in:
- BMC Urology, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2490-14-49
- By:
- Publication type:
- Article
Disease-specific outcomes of radical prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Prediction of recurrence from metabolites and expression of TOP2A and EZH2 in prostate cancer patients treated with radiotherapy.
- Published in:
- NMR in Biomedicine, 2023, v. 36, n. 5, p. 1, doi. 10.1002/nbm.4694
- By:
- Publication type:
- Article
Spatially matched in vivo and ex vivo MR metabolic profiles of prostate cancer - investigation of a correlation with Gleason score.
- Published in:
- NMR in Biomedicine, 2013, v. 26, n. 5, p. 600, doi. 10.1002/nbm.2901
- By:
- Publication type:
- Article
Relative Enhanced Diffusivity in Prostate Cancer: Protocol Optimization and Diagnostic Potential.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Exploring the diagnostic potential of adding T2 dependence in diffusion-weighted MR imaging of the prostate.
- Published in:
- PLoS ONE, 2021, v. 16, n. 5, p. 1, doi. 10.1371/journal.pone.0252387
- By:
- Publication type:
- Article
Identification of metabolites from 2D ¹H-<sup>13</sup>C HSQC NMR using peak correlation plots.
- Published in:
- BMC Bioinformatics, 2014, v. 15, n. 1, p. 649, doi. 10.1186/s12859-014-0413-z
- By:
- Publication type:
- Article
Multiparametric Prostate MRI in Biopsy-Naïve Men: A Prospective Evaluation of Performance and Biopsy Strategies.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.745657
- By:
- Publication type:
- Article
Detection of Recurrent Prostate Cancer With <sup>18</sup>F-Fluciclovine PET/MRI.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.582092
- By:
- Publication type:
- Article
Gene signatures ESC, MYC and ERG-fusion are early markers of a potentially dangerous subtype of prostate cancer.
- Published in:
- BMC Medical Genomics, 2014, v. 7, p. 1, doi. 10.1186/1755-8794-7-50
- By:
- Publication type:
- Article
A PET/MRI study towards finding the optimal [F]Fluciclovine PET protocol for detection and characterisation of primary prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 4, p. 695, doi. 10.1007/s00259-016-3562-7
- By:
- Publication type:
- Article
Reducing prostate biopsies and magnetic resonance imaging with prostate cancer risk stratification.
- Published in:
- BJUI Compass, 2022, v. 3, n. 5, p. 344, doi. 10.1002/bco2.146
- By:
- Publication type:
- Article
Tissue Microstructure Is Linked to MRI Parameters and Metabolite Levels in Prostate Cancer.
- Published in:
- Frontiers in Oncology, 2016, p. 1, doi. 10.3389/fonc.2016.00146
- By:
- Publication type:
- Article
Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy.
- Published in:
- British Journal of Cancer, 2018, v. 118, n. 6, p. e11, doi. 10.1038/bjc.2017.470
- By:
- Publication type:
- Article
Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The Effect of Including Bone in Dixon-Based Attenuation Correction for <sup>18</sup>F-Fluciclovine PET/MRI of Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 12, p. 1913, doi. 10.2967/jnumed.118.208868
- By:
- Publication type:
- Article
Combined <sup>18</sup>F-Fluciclovine PET/MRI Shows Potential for Detection and Characterization of High-Risk Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 5, p. 762, doi. 10.2967/jnumed.117.198598
- By:
- Publication type:
- Article
A new method to provide a fresh frozen prostate slice suitable for gene expression study and MR spectroscopy.
- Published in:
- Prostate, 2011, v. 71, n. 5, p. 461, doi. 10.1002/pros.21260
- By:
- Publication type:
- Article
Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non‐metastatic high‐risk prostate cancer (SPCG 19/GRand‐P).
- Published in:
- BJU International, 2024, v. 133, n. 6, p. 680, doi. 10.1111/bju.16314
- By:
- Publication type:
- Article
Performance of magnetic resonance imaging‐based prostate cancer risk calculators and decision strategies in two large European medical centres.
- Published in:
- BJU International, 2024, v. 133, n. 3, p. 278, doi. 10.1111/bju.16163
- By:
- Publication type:
- Article
Simultaneous <sup>18</sup>F-fluciclovine Positron Emission Tomography and Magnetic Resonance Spectroscopic Imaging of Prostate Cancer.
- Published in:
- Frontiers in Oncology, 2018, p. N.PAG, doi. 10.3389/fonc.2018.00516
- By:
- Publication type:
- Article
A Balanced Tissue Composition Reveals New Metabolic and Gene Expression Markers in Prostate Cancer.
- Published in:
- PLoS ONE, 2016, v. 11, n. 4, p. 1, doi. 10.1371/journal.pone.0153727
- By:
- Publication type:
- Article
Phosphatase of regenerating liver 3 (PRL-3) is overexpressed in human prostate cancer tissue and promotes growth and migration.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The Reproducibility of Deep Learning-Based Segmentation of the Prostate Gland and Zones on T2-Weighted MR Images.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 9, p. 1690, doi. 10.3390/diagnostics11091690
- By:
- Publication type:
- Article
Integrative metabolic and transcriptomic profiling of prostate cancer tissue containing reactive stroma.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-32549-1
- By:
- Publication type:
- Article
Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer.
- Published in:
- PLoS ONE, 2017, v. 12, n. 11, p. 1, doi. 10.1371/journal.pone.0189000
- By:
- Publication type:
- Article